Search results
Antibody-displaying extracellular vesicles for targeted cancer therapy - Nature Biomedical...
Nature· 4 days agoExtracellular vesicles decorated with an antibody-binding moiety specific for the fragment crystallizable domain can be used as a modular delivery system for targeted cancer therapy.
What Is the Rarest Blood Type?
Verywell Health via Yahoo News· 2 days agoHowever...several different subtypes of A, B, and Rh antigens. Sometimes, genetic testing can provide even more precise test results than routine blood...
Chronic Lyme Disease: Why COVID May Spark Better Tests and Treatment
Well and Good· 1 week agoPeople with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but...
Earnings call: OncoCyte outlines strategy amid Q1 revenue decline
Investing.com· 1 week agoOncoCyte (NASDAQ: OCX ) Corporation (NYSEAMERICAN: OCX), a diagnostic testing firm, recently held...
Clues from bird flu's ground zero on dairy farms in the Texas panhandle
ABC News· 5 hours agoThis is a KFF Health News story. In early February, dairy farmers in the Texas Panhandle began to notice sick cattle. The buzz soon reached Darren Turley, executive director of the Texas Association ...
ASCO: With hopes high, Regeneron misses mark with just 1 complete response in solid tumor trial so...
FierceBiotech· 18 hours agoRegeneron’s costimulatory bispecific antibody REGN7075 is being tested in patients with advanced...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 7 days agoBased on this positive data, Novo Nordisk plans to file regulatory applications for Mim8 by the end...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 26 minutes agoLunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response PR Newswire SEOUL, South Korea, May 24, ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 17 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific ...
These 21 Stories From Women Who Were Dismissed By Their Doctors Will Make Your Blood Boil
BuzzFeed via Yahoo News· 1 week agoFrustrated and in agony, I sought a second opinion at another urgent care down the road right after....
